Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOADEX dexamethasone implant loading protocol in diabetic macular edema
2024-514362-39-00Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2019
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of ozurdex in diabetic macular edema (DME), sponsored by Hospices Civils de Lyon. Started Dec 2019; status: completed.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2024-514362-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514362-39-00.